Westbridge Capital led a $22m Series B round in Truemeds.

Westbridge Capital, a private equity firm, led a $22m Series B round in Truemeds, a telehealth platform. “We are excited to partner with Truemeds as they create value for patients by delivering high quality drugs at extremely affordable prices at the patients' doorstep. The founding team’s strong category understanding has resulted in the success at Truemeds and we are excited to help take the company to the next level," Sandeep Singhal, Westbridge Capital Managing Director.